Sana Biotechnology
Sana Biotechnology
Lonza Boosts US Manufacturing with $12B Acquisition!
🚀 Lonza has acquired Roche's Vacaville site for $1.2 billion, boosting U.S. manufacturing and investing $591 million for upgrades! 🏭✨
Boston BPI 2024: Key Trends in Bioprocessing Revealed!
🌟 At BPI 2024, John Sterling & Julianna LeMieux shared key trends in bioprocessing! 🚀 Celebrating 20 years of innovation! 🧬✨
Boost Cell Growth with Custom Microcarriers!
**Excerpt:** 🌱 Discover how optimizing microcarriers can transform cell culture! 🧪 Custom solutions enhance growth, yielding over 20-fold production! 💡🔬
Unlocking Innovation: Biden’s Biomanufacturing Initiative Revealed!
🌱 Sarah Glaven opened the BPI Meeting, emphasizing Biden's Biomanufacturing Initiative's role in sustainability and innovation across sectors. 💡📊
Unlocking Biologics: Three Paths to Scale Production!
Biologics production can soar! 🚀 Explore scaling up, out, or down for optimal manufacturing flexibility and risk management. 📈🔄🔍💡
Is Your Biotech Project at Risk of Titre Issues?
🚨 Neglecting optimal manufacturing strains for biological therapeutics can derail projects and increase costs. Prioritize strain development for success! 💡💊📈
From Pond to Product: The Gellan Gum Revolution!
🌊 Discover the journey of gellan gum from pond to product! 🌿 Used in food, cosmetics, and pharmaceuticals. 🚀💡 ScienceMatters
Regeneron Cuts Costs by Streamlining AAV Production!
**Excerpt:** Regeneron revolutionizes AAV manufacturing by eliminating endonuclease! 🌟 Save up to $100,000 per batch while enhancing efficiency! 💰🔬⚙️
Sana Biotechnology Launches New Facility in WA!
Sana Biotechnology celebrates a new biomanufacturing facility in Bothell, WA, boosting cell and gene therapy production! 🎉🏭🧑🔬📦🤝
